The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. (Q50760156)
scientific article published in July 1995
Language:
(P31) (Q13442814)
(P304) 218-227
(P407) (Q1860)
(P433) 1
(P478) 65
(P577) Saturday, July 1, 1995
(P1104) 10
(P1433) (Q6295643)
(P1476) "The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides" (language: en)
(P2093) M S Shearman
S R Hawtin
V J Tailor
other details
description scientific article published in July 1995

External Links